MoneyWorks4Me

With no major difference for the quarter endedMarch 2026 , the total revenue stood at Rs. 9891.50  millions.Net profit stood at Rs. 2749.40  millions  compared to Rs. 2601.40 millions in the corresponding previous quarter,high by 5.69%.Operating profit for the quarter ended March 2026 rose to 3829.00 millions as compared to 3702.00 millions of corresponding quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 9891.50 9660.80 2.39 37902.00 37234.90 1.79 37902.00 37234.90 1.79
Other Income 357.10 394.60 -9.50 1425.60 1425.60 0.00 1425.60 1425.60 0.00
PBIDT 3829.00 3702.00 3.43 14427.60 13118.50 9.98 14427.60 13118.50 9.98
Interest 6.10 5.80 5.17 27.30 13.10 108.40 27.30 13.10 108.40
PBDT 3822.90 3696.20 3.43 14426.70 13152.30 9.69 14426.70 13152.30 9.69
Depreciation 131.70 147.20 -10.53 664.40 667.90 -0.52 664.40 667.90 -0.52
PBT 3691.20 3549.00 4.01 13762.30 12484.40 10.24 13762.30 12484.40 10.24
TAX 941.80 947.60 -0.61 3644.10 3293.80 10.64 3644.10 3293.80 10.64
Deferred Tax 69.40 54.20 28.04 94.60 62.00 52.58 94.60 62.00 52.58
PAT 2749.40 2601.40 5.69 10118.20 9190.60 10.09 10118.20 9190.60 10.09
Equity 1694.10 1694.10 0.00 1694.10 1694.10 0.00 1694.10 1694.10 0.00
PBIDTM(%) 38.71 38.32 1.02 38.07 35.23 8.04 38.07 35.23 8.04
Peers
Company Name CMP
Sun Pharma. Inds. 1847.55
Dr. Reddys Labs. 1142.10
Cipla 1355.20
Lupin 2043.20
Zydus Lifesciences 1097.20
View more..